HSK16149

· Haisco Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for HSK16149, covering 2020-12-01 to 2025-09-04. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Long-term Safety and Efficacy of HSK16149 in Chinese Patients With Peripheral Neuralgia [Phase 3]